Product Information
METOLAZONE 10 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3813 per EA under NDC 00378617401. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 23, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378617401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOLAZONEApproval Type
Generic (ANDA)
FDA Application
ANDA076698FDA Approved
12/23/2003
TE Code
AB
On Market Since
10/19/2004
Pharmacological Classes
Price Statistics
The NADAC for METOLAZONE 10 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 45.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3813 per EA |
|---|---|
| All-time high | $2.2491 (Dec 16, 2015) |
| All-time low | $0.3223 (Mar 18, 2026) |
| 52-week high | $0.4336 |
| 52-week low | $0.3223 |
| Median price | $1.2674 |
| Average price | $1.1455 |
| Largest weekly change | +63.7% (May 23, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the metolazone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metolazone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thiazide-like Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOLAZONE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METOLAZONE 10 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.3813 per EA (NDC 00378617401), effective Sep 30, 2026.
How has the price of METOLAZONE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for METOLAZONE 10 MG TABLET has declined 45.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METOLAZONE 10 MG TABLET?
Since Nov 28, 2013, the NADAC for METOLAZONE 10 MG TABLET has ranged from a low of $0.3223 (Mar 18, 2026) to a high of $2.2491 (Dec 16, 2015), with a median of $1.2674 per EA.
Are there cheaper alternatives to METOLAZONE 10 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of METOLAZONE 10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METOLAZONE 10 MG TABLET?
METOLAZONE 10 MG TABLET (NDC 00378617401) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.